Writing in the British Medical Journal (BMJ), the researchers noted treatment for attention-deficit/hyperactivity disorder (ADHD) had risen massively in recent years, even though its causes are unclear and drugs can have adverse effects.
ADHD is a disorder blamed for severe and frequent bouts of inattention, hyperactivity or impulsivity. Children and young adolescents are those who are most diagnosed with it.
But some experts fear the term ADHD may "medicalise" problems related to a child's personality or maturity level, the effects of poor parenting or other home problems.
In Australia, prescriptions for the stimulant Ritalin and other ADHD drugs rose by 72 percent between 2000 and 2011, while in Britain and the Netherlands prescriptions roughly doubled between 2003 and 2008, said the paper.
According to the US National Institute of Mental Health (NIMH), nearly one in 11 American children aged 13-18 and one in 25 adults are affected by ADHD.
The analysis noted that Ritalin and other drugs were meant to be used only for "severe" ADHD symptoms, which according to research data only occur among about 14 percent of children with the condition.
Yet "about 87 percent of children diagnosed with ADHD in the US in 2010 subsequently received medication," it said, warning of "unnecessary and possibly harmful medication treatment".
The study said the main ADHD drugs could have side effects like weight change, liver damage and dwelling on suicide. And the drugs' long-term impact, as a child moves into adulthood, remained unknown.
The study, led by Rae Thomas at the Centre for Research in Evidence-Based Practice at Australia's Bond University, did not dispute the existence of ADHD as a medical condition.
It noted that children who genuinely had a severe form of it ran the risk of failure at school and of social rejection.
But it called on doctors to follow a six-step programme of "watchful waiting" over 10 weeks to confirm that a child really did need help.
A separate study using lab rats suggested high, abusive doses of the chief ingredient in Ritalin stimulates a brain chemical mechanism implicated in drug addiction.
Rats were given the possibility of self-administering a dose of methylphenidate (MPH) in experiments led by Sara Jones at the Wake Forest University School of Medicine in North Caroline.
Repeated high doses of the substance released a neurochemical brake in the brain, boosting levels of the "pleasure" chemical called dopamine.
The results are important in the context of reports of widening use of MPH for a non-medical high, especially among US college students, said the paper in the journal Nature Communications on Tuesday.
"We think it (the reported abuse) is more dangerous than generally believed," Jones told AFP in a phone interview.
In rats, Ritalin caused the brain to become more sensitised to dopamine signals, which meant they did not need ever higher doses -- the opposite observed in cocaine trials.
This characteristic could make Ritalin a "gateway" drug, added to the fact that traces of it stayed in the body for a long time -- giving an added boost to a user simultaneously taking cocaine, amphetamines or other narcotics.
Jones said the rats gave themselves doses "probably between five and 10 times" the amount prescribed for children with ADHD.
"There were no effects (on the rats) from oral doses that you would typically prescribe to a child," she added. "That was comforting."